This handheld device is for Army battalion aid stations, brigade support aid stations,and field hospitals for triaging and evacuation decision making. Officials of the Medical Technology Enterprise Consortium (MTEC) in Summerville, S.C., issued a request for project proposals (MTEC-22-08-BDA) on Friday for the Burn Digital Assessment project.
These efforts have been successful, and Dr. Biris’ university spinout venture NuShores received a fourth award in FY20 by the U.S. Army’s Medical Research and Development Command’s Clinical and Rehabilitative Research Program (CRMRP) via an Other Transaction Agreement (OTA) competitively awarded through the Medical Technology Enterprise Consortium (MTEC). This transition of the initial NuCressTM manufacturing process from the JWMRP to the MTEC focuses on the optimization of the manufacturing process by investigating multiple and consecutive iterations of automation to improve quality, cost and efficiency. The deliverable is to demonstrate the feasibility of producing the NuCressTM bone void filler scaffold by a fully automated, intelligent production system with real-time in-process quality monitoring and control.
The award from the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development Command, is sponsored and will be managed by the Naval Medical Research Center (NMRC) to advance medical treatments for combat wounds and burns.
“Through MTEC, NMRC is harnessing the innovation of academia and the biotechnology sector to develop and eventually deliver technology to the warfighter,” said Thomas Dunn, acting program manager of NMRC’s Naval Advanced Medical Development department. “MTEC helps survey the scope of innovative research, and to see how that research can be used to meet the needs of military medicine.”
How exactly the ReHeal Glove got to where it is now—flush with funding and undergoing various rounds of testing—is largely due to the role of the Medical Technology Enterprise Consortium (MTEC), a nonprofit corporation that operates as the premier facilitator and collaborator across the entire DOD. Indeed, if it weren’t for MTEC, the near decade-long effort to develop the ReHeal Glove may have withered on the vine. Instead, it provides a promising medical option for millions.
Apheresis services firm Terumo Blood and Cell Technologies has entered into a contract with the Medical Technology Enterprise Consortium (MTEC), which is an Other Transaction Agreement (OTA) with the US Army Medical Research and Development Command.
MediWound Ltd., a fully-integrated biopharmaceutical company focused on next-generation bio therapeutic solutions for tissue repair and regeneration, today announced that the U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC), has awarded MediWound a $1.7 million research project for the development of NexoBrid® as a non-surgical solution for field-care burn treatment for the U.S. Army (the "MTEC Research Project Award").
The goal is to help the DoD better execute its National Defense Strategy by preventing various forms of violent, abusive and harmful acts within military contexts.
Across the country, the organizations are relieving stressed-out critical-care teams and filling in where necessary to fight COVID-19. The telehealth system is ready for other disasters, as well.
“We need to place cutting-edge technology quickly into the hands of the warfighter,” said Sara Langdon, USAMRDC’s program manager for other-transaction authority with the Medical Technology Enterprise Consortium (MTEC). “It is vital that we partner in order to fill our medical capability gaps, and OTAs help us to accomplish this.”
